![Ben Taylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ben Taylor
Financieel Directeur/CFO bij
RECURSION PHARMACEUTICALS, INC.
Vermogen: 4 M $ op 30-06-2026
Profiel
Ben R.
Taylor is currently Chief Financial Officer & President-UK Region at Recursion Pharmaceuticals, Inc. since 2024.
Former roles include Chief Financial Officer & Executive Director at Exscientia AI Ltd. from 2020 to 2024; Chief Financial & Strategy Officer, Director at Exscientia Ltd.; Head-Emerging Pharm at Goldman Sachs & Co. LLC from 2012 to 2016; Head-Commercial Pharm at Barclays Capital, Inc. from 2016 to 2017; Chief Financial Officer at Aetion, Inc. in 2020; and President & Chief Financial Officer at Tyme Technologies, Inc. from 2017 to 2020.
Education includes undergraduate studies at Brown University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 1.101.876 ( 0,21% ) | 4 M $ | 30-06-2026 |
Actieve functies van Ben Taylor
| Bedrijven | Functie | Begin |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 20-11-2024 |
Eerdere bekende functies van Ben Taylor
| Bedrijven | Functie | Einde |
|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Financieel Directeur/CFO | 01-11-2024 |
Aetion, Inc.
 Aetion, Inc. Packaged SoftwareTechnology Services Develops data collaboration, retrieval and privacy-preserving record linkage platform for healthcare industry | Financieel Directeur/CFO | 01-11-2020 |
| TYME TECHNOLOGIES, INC. | Financieel Directeur/CFO | 01-08-2020 |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01-01-2017 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01-02-2016 |
Opleiding van Ben Taylor
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
97
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Aetion, Inc.
Aetion, Inc. Packaged SoftwareTechnology Services Develops data collaboration, retrieval and privacy-preserving record linkage platform for healthcare industry | Technology Services |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Health Technology |
Exscientia Plc
 Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
